Modulation of multidrug resistance by cepharanthine in fresh human gastrointestinal tumor cells

被引：0

作者：

Hotta, T ^{[1
]}

Tanimura, H ^{[1
]}

Yamaue, H ^{[1
]}

Iwahashi, M ^{[1
]}

Tani, M ^{[1
]}

Tsunoda, T ^{[1
]}

Tamai, M ^{[1
]}

Noguchi, K ^{[1
]}

Mizobata, S ^{[1
]}

Arii, K ^{[1
]}

Terasawa, H ^{[1
]}

机构：

[1] WAKAYAMA MED COLL,DEPT SURG 2,WAKAYAMA 640,JAPAN

来源：

ONCOLOGY | 1997年 / 54卷 / 02期

关键词：

multidrug resistance; P-glycoprotein; doxorubicin; cepharanthine;

D O I：

暂无

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

Resistance to doxorubicin (DOX) is mainly due to the effect of P-glycoprotein encoded by the multidrug resistance (MDR) gene. Cepharanthine (CEP) has been shown to circumvent multidrug resistance in P-glycoprotein-expressing cell lines. In the present study, we investigated the augmentation of DOX sensitivity by CEP using an MTT assay, and assessed the correlation between DOX sensitivity and P-glycoprotein expression by flow cytometry, in highly purified fresh human tumor cells obtained from 73 cancer patients. DOX sensitivity was decreased in proportion to P-glycoprotein expression. The cytotoxicity of DOX was increased by CEP in tumor cells possessing low DOX P-glycoprotein sensitivity. Moreover, there was a significant correlation between the effect of Doxorubicin CEP on cytotoxicity and P-glycoprotein expression. Thus, CEP might be able Cepharanthine to circumvent DOX resistance in cancer patients.

引用

页码：153 / 157

页数：5

共 50 条

[1] Synergistic effects of tamoxifen and cepharanthine for circumventing the multidrug resistance
Hotta, T
Tanimura, H
Yamaue, H
Iwahashi, M
Tani, M
Tsunoda, T
Noguchi, K
Mizobata, S
Terasawa, H
CANCER LETTERS, 1996, 107 (01) : 117 - 123
[2] Cellular mechanisms of multidrug resistance of tumor cells
Stavrovskaya, AA
BIOCHEMISTRY-MOSCOW, 2000, 65 (01) : 95 - 106
[3] Modulation of Mitochondrial Permeability Transition Pore Affects Multidrug Resistance in Human Hepatocellular Carcinoma Cells
Ling, Xianlong
Zhou, Yuan
Li, Shi-Wei
Yan, Bin
Wen, Lei
INTERNATIONAL JOURNAL OF BIOLOGICAL SCIENCES, 2010, 6 (07): : 773 - 783
[4] Dynamic Assessment of Mitoxantrone Resistance and Modulation of Multidrug Resistance by Valspodar (PSC833) in Multidrug Resistance Human Cancer Cells
Shen, Fei
Bailey, Barbara J.
Chu, Shaoyou
Bence, Aimee K.
Xue, Xinjian
Erickson, Priscilla
Safa, Ahmad R.
Beck, William T.
Erickson, Leonard C.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS, 2009, 330 (02) : 423 - 429
[5] MODULATION OF DOXORUBICIN RESISTANCE IN MULTIDRUG-RESISTANT CELLS BY LIPOSOMES
THIERRY, AR
VIGE, D
COUGHLIN, SS
BELLI, JA
DRITSCHILO, A
RAHMAN, A
FASEB JOURNAL, 1993, 7 (06) : 572 - 579
[6] Modulation of P-glycoprotein function and reversal of multidrug resistance by (-)-epigallocatechin gallate in human cancer cells
Qian, F
Wei, DZ
Zhang, Q
Yang, SL
BIOMEDICINE & PHARMACOTHERAPY, 2005, 59 (03) : 64 - 69
[7] Modulation of P-glycoprotein by Stemona alkaloids in human multidrug resistance leukemic cells and structural relationships
Umsumarng, Sonthaya
Pitchakarn, Pornsiri
Yodkeeree, Supachai
Punfa, Wanisa
Mapoung, Sariya
Ramli, Rosdayati Alino
Pyne, Stephen G.
Limtrakul, Pornngarm
PHYTOMEDICINE, 2017, 34 : 182 - 190
[8] GENETIC-BASIS OF MULTIDRUG RESISTANCE OF TUMOR-CELLS
KANE, SE
PASTAN, I
GOTTESMAN, MM
JOURNAL OF BIOENERGETICS AND BIOMEMBRANES, 1990, 22 (04) : 593 - 618
[9] Modulation of multidrug resistance in cancer cells by chelidonine and Chelidonium majus alkaloids
El-Readi, Mahmoud Zaki
Eid, SafaaYehia
Ashour, Mohamed Lotfy
Tahrani, Ahmad
Wink, Michael
PHYTOMEDICINE, 2013, 20 (3-4) : 282 - 294
[10] Avermectins inhibit multidrug resistance of tumor cells
Korystov, YN
Ermakova, NV
Kublik, LN
Levitman, MK
Shaposhnikova, VV
Mosin, VA
Drinyaev, VA
Kruglyak, EB
Novik, TS
Sterlina, TS
EUROPEAN JOURNAL OF PHARMACOLOGY, 2004, 493 (1-3) : 57 - 64

← 1 2 3 4 5 →